Skip to content

Clinical trials

Terminated Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Terminated Country / region: United States Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20074
20093
20102
20112
20122
20148
20155
20164
20177
20181
20197
20206
20216
202211
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated76

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic4
Incyte Corporation3
M.D. Anderson Cancer Center3
Stanford University3
Weill Medical College of Cornell University3
Alaunos Therapeutics2
Medical University of South Carolina2
QED Therapeutics, a BridgeBio company2
University of Utah2
University of Washington2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma76
Biliary Tract Neoplasms15
Colorectal Neoplasms14
Carcinoma, Hepatocellular12
Pancreatic Neoplasms12
Bile Duct Neoplasms11
Gallbladder Neoplasms11
Ovarian Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Esophageal Neoplasms8

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.